Genome & Company (KOSDAQ:314130)
2,575.00
+15.00 (0.59%)
Last updated: Aug 29, 2025, 9:07 AM KST
Genome & Company Market Cap
Genome & Company has a market cap or net worth of 79.58 billion as of August 28, 2025. Its market cap has decreased by -47.68% in one year.
Market Cap
79.58B
Enterprise Value
73.64B
Revenue
24.02B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,575.00
Market Cap Chart
Since December 26, 2018, Genome & Company's market cap has increased from 71.88B to 79.58B, an increase of 10.71%. That is a compound annual growth rate of 1.54%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 27, 2025 | 81.75B | -4.05% |
Dec 30, 2024 | 85.21B | -51.64% |
Dec 28, 2023 | 176.21B | -28.34% |
Dec 29, 2022 | 245.90B | -47.55% |
Dec 30, 2021 | 468.83B | -55.28% |
Dec 30, 2020 | 1,048.46B | 224.28% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 26, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 461.60T |
SK hynix | 179.51T |
LG Energy Solution | 87.40T |
Samsung Biologics | 72.60T |
Hyundai Motor Company | 48.05T |
Hanwha Aerospace | 46.66T |
HD Hyundai Heavy Industries | 46.25T |
Kia Corporation | 40.79T |